FAKTOR OPTIONSSCHEIN - BALCHEM CO. Stock

Certificat

DE000GX39Z68

Market Closed - BOERSE MUENCHEN 14:27:18 2024-06-07 EDT
0.452 EUR +1.35% Intraday chart for FAKTOR OPTIONSSCHEIN - BALCHEM CO.
Current month-3.83%
1 month+8.13%
Date Price Change
24-06-07 0.452 +1.35%
24-06-06 0.446 +12.91%
24-06-05 0.395 -9.61%
24-06-04 0.437 +3.31%
24-06-03 0.423 -10.00%

Real-time BOERSE MUENCHEN

Last update June 07, 2024 at 02:27 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying BALCHEM CORPORATION
Issuer Goldman Sachs
WKN GX39Z6
ISINDE000GX39Z68
Date issued 2021-11-05
Strike 184.6 $
Maturity Unlimited
Parity 66.61 : 1
Emission price 10.01
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 26.35
Lowest since issue 0.395
Spread 0.01
Spread %2.17%

Company Profile

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Sector
-
More about the company

Ratings for Balchem Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Balchem Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
152.2 USD
Average target price
166 USD
Spread / Average Target
+9.03%
Consensus